Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2019-05-01
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Integrated Treatment in FND (Functional Neurological Disorders)
NCT04310670
Body Signal Integration Training: A Case Series
NCT05941702
Movement Disorders and Early Maladaptive Schemas
NCT03717376
Metacognitive Therapy and Neuro-physiotherapy as a Treatment for Functional Movement Disorders
NCT05323344
Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND
NCT06362161
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Currently there is little treatment to offer after diagnosis, this study will investigate the feasibility and potential benefit to offering a group intervention to people with FND. This group intervention will offer chance to access information and the opportunity to meet others with the similar difficulties. Eligible participants will be those currently attending neurology clinics within NHS Grampian. Participants will complete prior to, during and at 3 months after the group is completed. These measures include health care use of participants, reported physical symptoms, subjective quality of ife and mood we will also take a brief measure of attention and concentration. Reported physical symptoms, subjective quality of life and mood will also be collected before the first group and at the last group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Brief Psychoeducation Intervention
2 group session psychoeducation intervention feasibility study
Psychoeducation Group for FND
he intervention is a psychoeducation based group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Psychoeducation Group for FND
he intervention is a psychoeducation based group.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* People who are unable to understand the information sheet due to English not being their first language.
* Severe sensory impairment.
* Anyone experiencing active severe psychiatric symptoms
* A dependency on alcohol or recreational drugs
* Learning disability as classified by ICD 10.
* Those unable to travel independently to attend group sessions due to the severity of their symptoms
18 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NHS Grampian
OTHER_GOV
University of Edinburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr Pauline M Insch
Role: PRINCIPAL_INVESTIGATOR
University of Edinburgh/NHS Grampian
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NHS Grampian
Aberdeen, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18/NS/0137
Identifier Type: OTHER
Identifier Source: secondary_id
CAHSS189/05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.